$ Value
$41K
Shares
1,923
Price
$21
Filed
Jan 15
Insider
Name
GOLDSTEIN DOV A MD
Title
Chief Financial Officer
CIK
0001120478
Roles
Transaction Details
Transaction Date
2026-01-13
Code
S
Table
Non-Derivative
Ownership
Direct
Equity Swap
No
Shares After
22,408
Footnotes
This transaction was executed pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on December 2, 2024. | The reported price in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.00 to $18.91 per share, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote and in footnotes 3 through 5 of this Form 4. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $19.00 to $19.86 per share, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $20.04 to $21.02 per share, inclusive. | The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $21.04 to $21.15 per share, inclusive. | The option vested or vests as to 1/48th of the total award monthly, with the first tranche vesting on May 17, 2024, and each subsequent tranche vesting on the monthly anniversary thereof, subject to the reporting person's continued service to the Issuer on each vesting date. Additionally, the entire award is exercisable at any time pursuant to an early exercise feature of the option award.
Filing Info
GOLDSTEIN DOV A MD's History
| Date | Ticker | Type | Value |
|---|---|---|---|
| 2026-03-01 | BIOA | M | $16K |
| 2026-03-01 | BIOA | M | $0 |
| 2026-02-17 | BIOA | A | $0 |
| 2026-02-01 | BIOA | M | $16K |
| 2026-02-01 | BIOA | M | $0 |
| 2026-01-16 | BIOA | M | $16K |
| 2026-01-16 | BIOA | M | $0 |
| 2026-01-13 | BIOA | M | $227K |
| 2026-01-13 | BIOA | ▼ | $165K |
| 2026-01-13 | BIOA | ▼ | $86K |
Other Insiders at BIOA (90d)
| Insider | Bought | Sold | Last |
|---|---|---|---|
|
GOLDSTEIN DOV A MD
Chief Financial Officer
|
— | — | 2026-03-01 |
|
RUBIN PAUL D
Chief Medical Officer
|
— | $447K | 2026-04-01 |
|
Barton Shane
Principal Accounting Officer
|
— | — | 2026-02-17 |
|
Fortney Kristen
Chief Executive Officer
|
— | — | 2026-02-17 |
|
Morgen Eric
Chief Operating Officer
|
— | — | 2026-02-17 |